Propanc Biopharma, Inc. (PPCB) › Shares OutstandingPropanc Biopharma, Inc. (PPCB) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2011: 71.92M2012: 72.71M2013: 70.63M2014: 72.68M2015: 347.44M2016: 2.91M2017: 4.55M2018: 92.8K2019: 968.0K2020: 258.1K2021: 14.06M2022: 220.4K2023: 6.03M2024: 8.0K2025: 11.61M11.61M2011Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202511.61M+145411.1%20248.0K-99.9%20236.03M+2637.1%2022220.4K-98.4%202114.06M+5345.3%2020258.1K-73.3%2019968.0K+943.0%201892.8K-98.0%20174.55M+56.2%20162.91M-99.2%2015347.44M+378.0%201472.68M+2.9%201370.63M-2.9%201272.71M+1.1%201171.92M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share